ARDELYX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ARDELYX, INC. (ARDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 3.97 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.02M shares, a 34.21% increase year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.95M shares, a 28.32% decline year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 1.45M shares, a 55.34% increase year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 2.68M shares, a 111.67% increase year-over-year.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 9.01M shares, a 6.85% decline from fiscal 2024.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 9.67M shares, a 8.53% increase from fiscal 2023.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 8.91M shares, a 65.32% increase from fiscal 2022.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 5.39M shares, a 58.14% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 3.97M shares 10-Q · filed 2026-08-06 | 5.42M shares derived: sum of 3 quarters · filed 2026-08-06 | 8.11M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 2.95M shares 10-Q · filed 2026-04-30 | 4.40M shares derived: sum of 2 quarters · filed 2026-04-30 | 7.09M shares derived: sum of 3 quarters · filed 2026-04-30 | 7.85M shares derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | 1.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 4.14M shares derived: sum of 2 quarters · filed 2026-02-19 | 4.90M shares derived: sum of 3 quarters · filed 2026-02-19 | 9.01M shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 2.68M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | 3.44M shares derived: sum of 2 quarters · filed 2025-10-30 | 7.56M shares 10-Q · filed 2025-10-30 | 8.49M shares derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | 760.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 4.87M shares 10-Q · filed 2025-08-04 | 5.81M shares derived: sum of 3 quarters · filed 2025-08-04 | 7.08M shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 4.11M shares 10-Q · filed 2025-05-01 | 5.05M shares derived: sum of 2 quarters · filed 2025-05-01 | 6.32M shares derived: sum of 3 quarters · filed 2025-05-01 | 7.29M shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 936.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | 2.20M shares derived: sum of 2 quarters · filed 2025-02-20 | 3.17M shares derived: sum of 3 quarters · filed 2025-02-20 | 9.67M shares 10-K · filed 2025-02-20 |
| 2024-09-30 | 1.27M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 2.24M shares derived: sum of 2 quarters · filed 2024-10-31 | 8.74M shares 10-Q · filed 2024-10-31 | 10.14M shares derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | 968.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 7.47M shares 10-Q · filed 2024-08-01 | 8.87M shares derived: sum of 3 quarters · filed 2024-08-01 | 9.05M shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 6.50M shares 10-Q · filed 2024-05-02 | 7.90M shares derived: sum of 2 quarters · filed 2024-05-02 | 8.09M shares derived: sum of 3 quarters · filed 2024-05-02 | 8.94M shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 1.58M shares derived: sum of 2 quarters · filed 2024-02-22 | 2.44M shares derived: sum of 3 quarters · filed 2024-02-22 | 8.91M shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 181.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 1.04M shares derived: sum of 2 quarters · filed 2023-10-31 | 7.51M shares 10-Q · filed 2023-10-31 | 8.03M shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 859.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 7.33M shares 10-Q · filed 2023-08-02 | 7.85M shares derived: sum of 3 quarters · filed 2023-08-02 | 7.95M shares derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | 6.47M shares 10-Q · filed 2023-05-03 | 6.99M shares derived: sum of 2 quarters · filed 2023-05-03 | 7.09M shares derived: sum of 3 quarters · filed 2023-05-03 | 8.33M shares derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | 515.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 619.00K shares derived: sum of 2 quarters · filed 2023-03-02 | 1.86M shares derived: sum of 3 quarters · filed 2023-03-02 | 5.39M shares 10-K · filed 2023-03-02 |
| 2022-09-30 | 104.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 1.34M shares derived: sum of 2 quarters · filed 2022-11-03 | 4.88M shares 10-Q · filed 2022-11-03 | 4.88M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 1.24M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 4.77M shares 10-Q · filed 2022-08-04 | 4.77M shares derived: sum of 3 quarters · filed 2022-08-04 | 4.85M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 3.54M shares 10-Q · filed 2022-05-05 | 3.53M shares derived: sum of 2 quarters · filed 2022-05-05 | 3.62M shares derived: sum of 3 quarters · filed 2022-05-05 | 4.14M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | -281.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 81.72K shares derived: sum of 2 quarters · filed 2022-02-28 | 609.72K shares derived: sum of 3 quarters · filed 2022-02-28 | 3.41M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 82.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 610.00K shares derived: sum of 2 quarters · filed 2021-11-12 | 3.41M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 528.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | 3.33M shares 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | 2.80M shares 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 3.73M shares 10-K · filed 2021-03-08 | |||
| 2019-12-31 | 2.36M shares 10-K · filed 2020-03-06 | |||
| 2018-12-31 | 2.57M shares 10-K · filed 2019-03-06 | |||
| 2017-12-31 | 1.72M shares 10-K · filed 2019-03-06 | |||
| 2016-12-31 | 1.52M shares 10-K · filed 2019-03-06 | |||
| 2015-12-31 | 379.71K shares 10-K · filed 2018-03-14 | |||
| 2014-12-31 | 125.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | 125.00K shares derived: sum of 2 quarters · filed 2017-02-17 | 188.89K shares 10-K · filed 2017-02-17 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-07 | 63.89K shares 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | 63.89K shares 10-Q · filed 2014-08-08 | |||
| 2013-12-31 | 99.55K shares 10-K · filed 2016-03-04 | |||
| 2012-12-31 | 81.23K shares 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |